Method development & validation for the estimation of Olmesartan medoxomil from pure & tablet dosage forms by UV- visible spectroscopy

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{206313,
        author = {E.Naga Deepthi and B.Deepika and K. Sujatha and Y.S. Jubina and Mohammed Aseef and M. Vamshi yadav},
        title = {Method development & validation for the estimation of Olmesartan medoxomil from pure & tablet dosage forms by UV- visible spectroscopy},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {2},
        pages = {1435-1440},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=206313},
        abstract = {},
        keywords = {Olmesartan medoxomil, UV-spectrophotometric method, method validation, ICH Q2(R1), bulk drug, tablet dosage form.},
        month = {July},
        }

Cite This Article

Deepthi, E., & B.Deepika, , & Sujatha, K., & Jubina, Y., & Aseef, M., & yadav, M. V. (2026). Method development & validation for the estimation of Olmesartan medoxomil from pure & tablet dosage forms by UV- visible spectroscopy. International Journal of Innovative Research in Technology (IJIRT), 13(2), 1435–1440.

Related Articles